AddLife acquires Austrian Biomedica – international expansion on 13 new markets

26.11.2018 – 14:00 Life science group AddLife is continuing on its growth journey and is now taking an important step in its expansion and internationalisation strategy by acquiring Austrian Biomedica Medizinprodukte GmbH (“Biomedica”). Biomedica, which is the parent company of a group with sales of about EUR 65 million, engages in operations in 13 countries... Read more

Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies

KEELE, England, PORT WASHINGTON, N.Y. and LONDON, Nov. 26, 2018 /PRNewswire/ — Cobra Biologics, an international contract development and manufacturing organization (CDMO) with a focus on advanced therapy medicinal products (ATMPs) has won a £1.5M shared grant from Innovate UK, the United Kingdom’s innovation agency. Co-winners, Pall Corporation, a global leader in filtration, separation and purification, and the Cell and Gene Therapy Catapult, an independent research and technology organization... Read more

MTS Completes Acquisition Of E2M Technologies B.V.

EDEN PRAIRIE, Minn., Nov. 26, 2018 /PRNewswire/ — MTS Systems Corporation (Nasdaq: MTSC), a leading global supplier of high-performance test systems and sensors, announced today that it closed on the acquisition of E2M Technologies B.V. (“E2M”) on November 21, 2018. Significantly expands MTS Test and Simulation technology and product offerings for human-rated simulation systems Brings... Read more

ATI and Bruker Announce Agreement to Further Advance Niobium-Based Superconductor Technology and Manufacturing Processes

PITTSBURGH, Pennsylvania, November 26, 2018 – Allegheny Technologies Incorporated (NYSE: ATI) and Bruker Energy & Supercon Technologies (BEST), a wholly owned subsidiary of Bruker Corporation, today announced that they have entered into a joint technology development agreement to advance state-of-the-art niobium-based superconductors, including those used in magnetic resonance imaging (MRI) magnets for the medical industry,... Read more

Syntropy to Unlock the Value of Scientific Data in Fight to End Cancer

19 NOV 2018 | PALO ALTO, CALIFORNIA, UNITED STATES OF AMERICA Joint venture between Merck KGaA, Darmstadt, Germany, and Palantir Technologies being created to advance cancer research To empower scientists and research centers with the leading data integration and analytics technology To allow users to collaborate to drive scientific discovery, while ensuring control, ownership and traceability of... Read more

Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health

Sunnyvale, Nov. 05, 2018 (GLOBE NEWSWIRE) — Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces an allergy testing agreement with Northern California healthcare leader Sutter Health. The company is providing its proprietary microarray-based finger stick allergy testing services to Sutter Health via doctors in the Sutter Health-affiliated Palo Alto Medical Foundation. Sutter Health,... Read more

TIAA Bank Acquires $1.5 Billion Healthcare Equipment Financing Portfolio from GE Capital

Jacksonville, Fla., November 16, 2018 — TIAA Bank announced today the acquisition of a $1.5 billion portfolio of healthcare equipment leases and loans from GE Capital’s Healthcare Equipment Finance (HEF) business. This significantly expands TIAA Bank’s commercial banking business and enhances its ability to provide a full range of financial solutions to institutional clients and... Read more

Halma acquires innovative British radar surveillance and safety solutions company

16 November 2018 Halma has acquired Navtech Radar Ltd in a move that will add new capabilities to our Infrastructure Safety sector. Navtech Radar is a provider of innovative radar surveillance and safety solutions for use in highway monitoring, perimeter security and industrial applications. Based in Wantage, UK, Navtech combines radar, cameras and software to improve... Read more

Sartorius Stedim Biotech and Lonza Modify Relationship for Supply of Cell Culture Media

Sartorius Stedim Biotech will continue to offer Lonza media and buffer products but under a non-exclusive agreement Lonza selects Sartorius Stedim Biotech as preferred supplier for equipment and consumables Aubagne, November 15, 2018 – Sartorius Stedim Biotech (SSB), a leading international supplier of the biopharmaceutical industry, and Lonza announced today that they have modified their current... Read more